• Transactions
  • M&A / Private Equity
  • The 16 May 2019

MBA advises XAnge on TreeFrog Therapeutics fundraising

Back

The law firm MBA (Moisand Boutin & Associés) advised XAnge on its $ 7.1 million stake in TreeFrog Therapeutics’ Series A fundraising.

TreeFrog Therapeutics is a company specialized in the industrial production of stem cells.

The MBA team was composed of Jean-Philippe Jacob, partner and Eric du Peloux, counsel.

Sébastien Peronne, a partner at Altaïr Avocats, acted as counsel to the founders and the target company.